About
The history
The mission
Corporate
Board of Directors
Management Team
Scientific Advisors
R&D
Understanding tumor development
The importance of targeted therapies
Antiangiogenic therapy
Delivery platforms
Pipeline
Intellectual Property
Products
Newsroom
Publications
Awards
News
CONTACT US
Social links
Search
Monday Nov 10th, 2025
PEGASEMP – Nanoparticle developed in the University of Coimbra for the treatment of Breast Cancer
December 12, 2010
SIC Notícias
Tweet
NEWSROOM
Publications
Awards
News
Recent News
PEGASEMP™, the lead product of TREAT U, received the Orphan Drug Designation for the treatment of malignant mesothelioma
May 21, 2018
Vera Moura, CEO of TREAT U: “Life Sciences entrepreneurship is all about passion!”
July 27, 2017
TREAT U at BIO International 2017
June 22, 2017
Archives
Select Month
May 2018 (1)
July 2017 (1)
June 2017 (1)
May 2017 (1)
April 2017 (1)
October 2016 (2)
September 2016 (1)
December 2015 (1)
June 2015 (2)
March 2015 (1)
September 2014 (1)
June 2014 (1)
April 2014 (1)
January 2014 (1)
September 2013 (1)
April 2013 (1)
December 2012 (2)
November 2012 (1)
July 2012 (1)
April 2012 (1)
January 2012 (1)
December 2011 (1)
September 2011 (3)
February 2011 (1)
December 2010 (1)
April 2010 (2)
September 2009 (1)
Brochure
SHORTCUTS
Sitemap
Privacy Statement
Terms of Use
Tweet
CONTACT DETAILS
TREAT
U
Parque Industrial de Taveiro
Lote 44, 3045-508 Coimbra
Portugal
Email:
info@treatu.pt
Copyright 2012. All rights reserved. Design by
NT
Scroll to top